fifty-seven patients undergoing bone marrow transplantation were randomly assigned to receive either cyclosporin a ( csa , n = 26 ) or methotrexate , followed by rescue with folinic acid ( mtx + fa , n = 31 ) as prophylaxis for graft-versus-host disease ( gvhd ) .
C0010592
cyclosporin a
C0018133
graft-versus-host disease